DAWN Stock Ownership Activity

DAY ONE BIOPHARMACEUTICALS I 13F holders

1 value investing guru has made changes to the DAY ONE BIOPHARMACEUTICALS I (DAWN) position according to the gurus' latest SEC quarterly report(s). DAWN has been completely sold out by 1 guru(s)

Which gurus or hedge funds are buying DAWN now?

According to the latest SEC filing(s) DAY ONE BIOPHARMACEUTICALS I (DAWN) has not been purchased by any super investor.

To see more about who is investing in DAY ONE BIOPHARMACEUTICALS I (DAWN), please go to the DAWN ownership page.

History
Name
Company
%
Activity
Share
Change
% change to
Portfolio
% of
Portfolio
2024 Q4 (1 result)
Ole Andreas Halvorsen
Viking Global Investors
-100.00%
-2,558,563
-0.12%
0.00%
Current price: $9.25 33.60% Reported price*: $13.93
2023 Q2 (1 result)
Ole Andreas Halvorsen
Viking Global Investors
+64.16%
+1,000,000
+0.05%
0.13%
Current price: $9.25 22.53% Reported price*: $11.94
2022 Q3 (1 result)
Ole Andreas Halvorsen
Viking Global Investors
-16.09%
-298,861
-0.03%
0.14%
Current price: $9.25 53.82% Reported price*: $20.03
2022 Q2 (1 result)
Ole Andreas Halvorsen
Viking Global Investors
+60.48%
+700,000
+0.06%
0.15%
Current price: $9.25 48.32% Reported price*: $17.90
2021 Q4 (1 result)
Ole Andreas Halvorsen
Viking Global Investors
-4.46%
-53,972
-0.00%
0.06%
Current price: $9.25 45.10% Reported price*: $16.85
2021 Q3 (1 result)
Ole Andreas Halvorsen
Viking Global Investors
-9.69%
-130,000
-0.01%
0.08%
Current price: $9.25 61.02% Reported price*: $23.73
2021 Q2 (1 result)
Ole Andreas Halvorsen
Viking Global Investors
buy
+1,341,396
+0.09%
0.09%
Current price: $9.25 59.38% Reported price*: $22.77
7 of 7

Shares, change to shares, sold shares - split-adjusted.

Reported price - this doesn't represent the actual buy or sell price.
It is the split-adjusted price of the security as of the last day of the reported period.

Value or Price - If the security is completely sold out, we show the reported value (or price) prior to the actual period.